SEC Stock Data

Quick Answer Acurx Pharmaceuticals, Inc. reported Net Income of -$7.97 million for fiscal year 2025. Acurx Pharmaceuticals, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Net Income -$7.97M+43.5% -$14.10M+3.3% -$14.58M-20.5% -$12.09M+5.1% -$12.75M-177.1% -$4.60M Diluted EPS -$5.32+69.5% -$17.45-1417.4% -$1.15-2.7% -$1.12+24.8% -$1.49-101.4% -$0.74 Total Assets $7.69M+99.3% $3.86M-50.0% $7.71M-17.8% $9.38M-29.3% $13.25M+311.1% $3.22M Stockholders … Read more

Quick Answer ACV Auctions Inc. reported Operating Income of -$63.19 million for fiscal year 2025. ACV Auctions Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$63.19M +24.9% 2024 -$84.11M +6.2% 2023 -$89.68M +15.6% 2022 -$106.21M -38.3% 2021 -$76.81M -89.0% 2020 -$40.65M +48.7% 2019 -$79.28M — Quarterly Operating Income Quarter Ending … Read more

Quick Answer ACV Auctions Inc. reported Stockholders Equity of $429.68 million for fiscal year 2025. ACV Auctions Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $429.68M -2.3% 2024 $440.00M -3.6% 2023 $456.53M -6.0% 2022 $485.72M -12.7% 2021 $556.10M +498.1% 2020 -$139.69M -31.6% 2019 -$106.14M -157.8% 2018 -$41.16M — Quarterly Stockholders … Read more

Quick Answer ACV Auctions Inc. reported Cash and Equivalents of $271.50 million for fiscal year 2025. ACV Auctions Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $271.50M +21.2% 2024 $224.06M +22.7% 2023 $182.57M -35.0% 2022 $280.75M -50.4% 2021 $565.99M +142.2% 2020 $233.72M +28.2% 2019 $182.28M +54.6% 2018 $117.89M … Read more

Quick Answer ACV Auctions Inc. reported Total Assets of $1.09 billion for fiscal year 2025. ACV Auctions Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $1.09B +10.3% 2024 $984.15M +6.6% 2023 $922.92M +0.9% 2022 $914.92M -6.9% 2021 $982.96M +143.0% 2020 $404.55M — Quarterly Total Assets Quarter Ending Total Assets YoY … Read more

Quick Answer ACV Auctions Inc. reported Diluted EPS of $0.39 per share (loss) for fiscal year 2025. ACV Auctions Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$0.39 +18.7% 2024 -$0.48 -2.1% 2023 -$0.47 +27.7% 2022 -$0.65 -4.8% 2021 -$0.62 +67.4% 2020 -$1.90 — Quarterly Diluted EPS Quarter Ending Diluted … Read more

Quick Answer ACV Auctions Inc. reported Net Income of -$66.14 million for fiscal year 2025. ACV Auctions Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$66.14M +17.0% 2024 -$79.70M -5.9% 2023 -$75.26M +26.4% 2022 -$102.19M -30.7% 2021 -$78.18M -90.6% 2020 -$41.02M +46.9% 2019 -$77.22M — Quarterly Net Income Quarter Ending … Read more

Quick Answer ACV Auctions Inc. reported Total Revenue of $759.61 million for fiscal year 2025. ACV Auctions Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $759.61M +19.2% 2024 $637.16M +32.4% 2023 $481.23M +14.2% 2022 $421.53M +17.6% 2021 $358.44M +72.0% 2020 $208.36M +95.0% 2019 $106.85M — Quarterly Total Revenue Quarter Ending … Read more

Quick Answer ACV Auctions Inc. reported Total Revenue of $759.61 million for fiscal year 2025. ACV Auctions Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $759.61M+19.2% $637.16M+32.4% $481.23M+14.2% $421.53M+17.6% $358.44M+72.0% $208.36M+95.0% Net Income -$66.14M+17.0% -$79.70M-5.9% -$75.26M+26.4% -$102.19M-30.7% -$78.18M-90.6% -$41.02M+46.9% Diluted EPS -$0.39+18.7% -$0.48-2.1% -$0.47+27.7% -$0.65-4.8% -$0.62+67.4% -$1.90 Total … Read more

Quick Answer Accustem Sciences Inc. reported Shares Outstanding of 12.10 million shares for fiscal year 2024. Accustem Sciences Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2024 12.10M +6.6% 2023 11.35M +0.0% 2022 11.35M +13.5% 2021 10.00M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, 2025 16.07M … Read more